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a b s t r a c t
Objective: To evaluate the modified US7 score (MUS7 score SYN) in the assessment of pa-
tients with early rheumatoid arthritis (ERA). In addition, dorsal and palmar recesses of the 
wrists as well as of small joints of the hands and feet were examined for the presence of 
synovitis by means of a global assessment of joints. 
Methods: The study sample comprised 32 patients treated for arthritis, with an average di-
sease duration of 13 months. An ultrasound machine with high frequency transducer was 
used. Hands were also X-rayed and analysed by Larsen score. 
Results: Out of the 832 examined joints, synovitis was detected in 173 (20,79%), tenosyno-
vitis in 22 (4,91%), and erosions in 3 (1,56%). Synovitis was predominantly detected in the 
dorsal recess (73,38%) of MCP and PIP joints, when compared with palmar recess (26%). 
The presence of synovitis in the joints evaluated correlated with clinical (HAQ-DI, DAS28), 
laboratory (ACPA, RF, CRP), and ultrasound results (r = 0,37 to r = 0,42; p = 0,04 to p = 0,003). 
We found correlation of the MUS7 score SYN of the gray scale US or of the power Doppler 
US with DAS28 (PCR) values (r = 0,38; p = 0,0332), and with CRP results (r = 0,39; p = 0,0280), 
respectively. 
Conclusion: The dorsal recess, the wrist, and small joints can be considered as important 
sites to detect synovitis by the MUS7 score SYN in patients with ERA.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
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r e s u m o
Objetivo: Avaliar o escore US7 modificado (escore MUS7 SIN) na avaliação de pacientes com 
artrite reumatoide inicial (ARI). Além disso, foram examinados recessos dorsais e palmares 
dos punhos, bem como pequenas articulações das mãos e dos pés, para o diagnóstico de 
sinovite, mediante uma avaliação global das articulações.
Métodos: A amostra do estudo compreendeu 32 pacientes tratados para artrite, com 13 me-
ses como duração média da doença. Foi utilizado um aparelho de ultrassonografia (US) com 
transdutor de alta frequência. As mãos dos participantes também foram radiografadas e 
analisadas pelo escore de Larsen.
Resultados: Nas 832 articulações examinadas, detectou-se sinovite em 173 (20,79%), tenossi-
novite em 22 (4,91%) e erosões em três (1,56%). A sinovite foi predominantemente detectada 
no recesso dorsal (73,38%) das articulações MCF e IFP, quando comparado com o recesso 
palmar (26%). A presença de sinovite nas articulações avaliadas teve correlação com os re-
sultados clínicos (HAQ-DI, DAS28), laboratoriais (anti-PCC, FR, PCR) e ultrassonográficos (r = 
0,37 a r = 0,42; p = 0,04 a p = 0,003). Encontramos correlação do escore MUS7 SIN para US na 
técnica da escala de cinzas (gray scale) ou na técnica de Doppler de amplitude (power Dop-
pler) com os valores do instrumento  DAS28 (PCR) (r = 0,38; p = 0,0332) e com os resultados 
da PCR (r = 0,39; p = 0,0280), respectivamente. 
Conclusão: O recesso dorsal, o punho e as pequenas articulações podem ser considerados 
como locais importantes para a detecção de sinovite pelo escore MUS7 SIN em pacientes 
com ARI.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory and sys-
temic disease that results in structural damage of synovium, 
cartilage, and bone. Because it is a chronic and progressive 
disease, it may result in joint deformities with functional loss 
and may compromise quality of life.
Early detection and careful characterization of the inflam-
matory process play a key role in both diagnostic and thera-
peutic procedures in RA.1 Currently, the most commonly used 
clinical instrument to determine the disease activity in RA 
patients is the 28-joint count Disease Activity Score (DAS28), 
which indirectly denotes the joint inflammatory status.2,3
Ultrasound (US) is a sensitive imaging technique for as-
sessment of anatomical changes, disease activity, and ther-
apy efficacy in patients with RA. Its sensitivity is greater 
than that of other imaging techniques in the early detection 
of aggressive arthritis and surveillance of disease activity.4-6 
Moreover, US is patient-friendly, safe and non-invasive, free 
of ionizing radiation, less expensive, and allows multiple tar-
get assessment in real time, besides therapeutic changes.7-10 
The semiquantitative US scoring system, US7 score, has been 
proposed to assess established RA and other inflammatory 
arthropathies.11 It was developed to standardize the US ex-
amination in daily rheumatologic practice and in multicenter 
studies. The US7 score includes the assessment of 7 joints us-
ing palmar and dorsal scan of the clinically dominant hand 
and foot including: wrist, second and third metacarpophalan-
geal (MCP) joints, second and third proximal interphalangeal 
(PIP) joints, and second and fifth metatarsophalangeal (MTP) 
joints. These joints have been evaluated for synovitis, tenosy-
novitis, paratenonitis, and bone erosion by semiquantitative 
scoring systems including grayscale (GS) and power Doppler 
(PD) techniques.12
To date, there are evidence demonstrating the ability of 
ultrasonography to detect synovitis in patients with early 
rheumatoid arthritis (ERA).13 Moreover, there is no consensus 
on which recess, dorsal or palmar, is the most sensitive for 
detecting synovitis by PD or GS. The aim of this study was 
to evaluate the feasibility of modified US7 score (MUS7 score 
SYN) in the assessment of synovitis in patients with ERA. In 
addition, dorsal and palmar recesses of the wrists and the 
small joints of the hands and feet were evaluated for the pres-
ence of synovitis by means of global assessment of joints.
Material and methods 
Patients
Thirty-nine ERA patients (30 women and 9 men) attending 
the outpatient and inpatient clinics of the Rheumatology De-
partment of Universidade Estadual de Campinas – UNICAMP 
– Campinas, São Paulo, Brazil, during a 2-year period were 
enrolled in this study. Inclusion criteria were as follows: age 
≥20 years; ≥3 months and <24 months of disease history, ac-
cording to the ACR 1987 revised criteria;14 and the presence of 
synovitis in at least one joint by US examination, according 
to 2010 ACR/EULAR Rheumatoid Arthritis Classification Cri-
teria.15 Seven patients were excluded from the study because 
they did not show synovitis in the US examination, according 
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to OMERACT criteria.12 Thus, a total of 32 patients (24 women 
and 8 men) with diagnosis of ERA comprised the final sample.
The study was approved by the Research Ethics Committee 
of the State University of Campinas (UNICAMP). The patients 
signed the Informed Consent and were informed about the 
guidelines for participation in the study. 
Clinical and laboratory assessment
The following clinical data were obtained: age, sex, race, time 
of onset of pain and articular swelling, dosage and duration of 
glucocorticoid treatment, and use of biological and disease-
modifying anti-rheumatic drugs (DMARDs). Patients were 
then blindly evaluated by a rheumatologist, by counting and 
recording the number of joints with swelling and tender to 
calculate the DAS28 (CRP) score. The patients were asked to 
fill in the health assessment questionnaire (HAQ).
All patients underwent the following laboratory tests: ESR, 
CRP, rheumatoid factor, and anti-cyclic citrullinated peptide 
(ACPA).
X-ray assessment
Conventional X-ray of wrists and hands was performed in 
anteroposterior projection. The radiographs were scored us-
ing the modified Larsen method and the feet were not evalu-
ated this study. Joints received the following grades: grade 0 
– normal, grade I – mild abnormality (presence of one or more 
of the following lesions: edema of soft tissues, osteopenia 
around the joint, and a slight decrease in joint space); grade II 
– definite abnormality (presence of small erosions, decreased 
joint space is not obligatory), grade III – marked abnormality 
(presence of erosions and decreased joint space), grade IV – se-
vere abnormality (the original joint surface remains partially 
preserved), and grade V – mutilating abnormality (the original 
joint surface has disappeared; huge deformity is present).16,17
US assessment
US examinations were performed using a General Electric 
LOGIQ Book XP Ultrasound machine (USA) equipped with a 
high frequency (8-10 MHz) linear transducer.
All joints were scanned using a multiplanar technique, 
adopting the indications provided by the EULAR guidelines 
for musculoskeletal ultrasound in rheumatology.18 In brief, 
the dorsal aspect of the wrist, and dorsal and palmar scans 
of MCP and PIP joints were examined by US with the patient 
seated with hands lying in prone position on the examina-
tion table. The longitudinal dorsal scan of MTP joints was per-
formed with the patient supine and legs bent at the knee.
The longitudinal scan was performed moving the trans-
ducer slightly from radial to ulnar on dorsal and palmar aspect 
to enable maximum coverage of the anatomical surface area. 
US grayscale imaging parameters were set to obtain the 
maximal contrast between all the structures under examina-
tion. PD settings were standardized at the following values: 
pulse repetition frequency: 800-900 MHz, frequency PD: 5.5 
MHz and low wall filter: Color gain was set just below the level 
at which color noise appeared in the underlying bone (no flow 
should be visualized at the bony surface). 
OMERACT preliminary definitions were adopted for the 
identification of synovial fluid and synovial hypertrophy.12
GS and PD for each target was graded on the basis of the 
semiquantitative scoring systems previously adopted. GS sy-
novitis was scored as follows: 0 – absence, 1 – mild (describes 
a small hypoechoic or an echoic line beneath the joint cap-
sule), 2 – moderate (the joint capsule is elevated parallel to the 
joint area), and 3 – severe or marked (characterizes the strong 
extensional of the joint capsule). PD findings were scored as 
follows: 0 – absence (no intra-articular color signal), 1 – mild 
(single signals or a confluent signal in the intra-articular 
area), 2 – moderate (greater than grade 1 to <50% of the intra-
articular area filled with colour signals), and 3 – marked (≥50% 
of the intra-articular area filled with color signals) (Fig. 1).19
The inter and intraobserver reliability of the US7 score 
showed moderate to substantial kappa values and good 
agreements and the median overall kappa for detecting sy-
novitis was 0.51.20
The US7 score includes a combination of semiquantitative 
GS and PD findings obtained by a formula that includes the 
sum of different parameters.11 Its score ranges from 0 to 39 for 
GS, and from 0 to 39 for PD. 
GS_synovitis (GSUS-Score 7) = GS_D _wrist + GS_P 
_wrist + GS_U _wrist + GS_D_MCP2 + GS_P_MCP2 
+ GS_D_MCP3 + GS_P_MCP3 + GS_D_PIP2 + GS_P_
PIP2 + GS_D_PIP3 + GS_P_PIP3 + GS_D_MTP2 + 
GS_D_MTP5 = 13 (scanning) x 3 (highest GS score 
0-3) = 39. 
PD_synovitis (PDUS-Score 7) = PD_D_wrist + 
PD_P_wrist + PD_U_wrist + PD_D_MCP2 + PD_P_
MCP2 + PD_D_MCP3 + PD_P_MCP3 + PD_D_PIP2 + 
PD_P_PIP2 + PD_D_PIP3 + PD_P_PIP3 + PD_D_MTP2 
+ PD_D_MTP5 = 13 (scanning) x 3 (highest PD 
score 0-3 ) = 39.
(1)
GS, grayscale; D, dorsal scan; P, palmar scan; U, ulnar scan; 
MCP, metacarpophalangeal joint; PIP, phalangeal interproxi-
mal; MTP, metatarsophalangeal joint; PD, power Doppler.
We developed a simplified US7 score for exclusive asses-
ment of synovitis. It does not consider the synovial evaluation 
of the palmar and ulnar recesses of the wrist joint, and of pal-
mar recess of the small joints for PD. The modified US7 score 
ranges from 0 to 33 for GS, and 0 to 21 for PD, and is calculated 
according to the following formula: 
GS_synovitis (GSUS-MUS7 score SYN) = GS_DC 
_wrist + GS_D_MCP2 + GS_P_MCP2 + GS_D_MCP3 + 
GS_P_MCP3 + GS_D_PIP2 + GS_P_PIP2 + GS_D_PIP3 
+ GS_P_PIP3 + GS_D_MTP2 + GS_D_MTP5 = 11(scan-
ning) x 3(highest GS score 0-3) = 33(max GS SYN) 
PD_synovitis (PDUS-MUS7 score SYN) = PD_DC_
wrist + PD_D_MCP2 + PD_D_MCP3 + PD_D_PIP2 + 
PD_D_PIP3 + PD_D_MTP2 + PD_D_MTP5 = 7(scanning) x 
3(highest PD score 0-3) = 21(max PD SYN)
(2)
GS, grayscale; SYN, synovitis; DC, dorsal central scan; P, 
palmar scan; MCP, metacarpophalangeal joint; PIP, phalange-
al interproximal; MTP, metatarsophalangeal joint; MUS7 score 
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SYN, modifi ed US7 Score for synovitis; max GS SYN, maxi-
mum possible score using grayscale; max PD SYN, maximum 
possible score using power Doppler.
Statistical analysis
The statistical analysis was performed with SAS System for 
Windows, version 9.2 (SAS Institute Inc, 2002-2008, Cary, NC, 
USA).
We performed a descriptive statistical analysis, present-
ing frequency tables for categorical variables and measures 
of position and dispersion for numerical variables. The Mann-
Whitney test was used for comparison of continuous and 
sequential measurements between the two clinical groups 
(pain and swelling of joints). The Spearman correlation coef-
fi cient was used to verify the linear correlation between the 
variables. The chi-square or Fisher exact tests were used to 
assess the association or to compare proportions, when nec-
essary. The weighted Kappa coeffi cient was used as a mea-
sure of agreement between observers.
Results
Thirty-two patients (8 male and 24 female) were included in 
the study, with an average age of 32.5 years. Two patients (6.2%) 
were smokers. Comorbidities were observed in 3 patients 
(9.3%): one was diagnosed with hypothyroidism, other with hy-
perthyroidism, and another with type 2 diabetes.
The average duration of the disease was 13.2 months. Table 
1 shows demographic, clinical, and laboratory data. 
Five (15.6%) patients were in clinical remission according to 
DAS28-CRP ≤2.6.
Twenty (62.5%) patients were treated with 12.5 to 25.0 mg 
methotrexate, 19 (59.3%) with 5 to 20 mg prednisone, and 1 
(3.1%) with biological agent. Seven (21.8%) patients were not 
using corticosteroids, disease-modifying anti-rheumatic drugs 
(DMARDs), or biological agents at the time of US examination. 
A total of 832 joints were examined, resulting in 173 (20.8%) 
joint recesses with synovitis. GSUS-examination revealed sy-
novitis in 22 (68.7%) right wrist joints, in 23 (71.8%) left wrist 
joints, and an increased synovial involvement of MCP (2) (right) 
in 17 joints (53.1%), of MCP (2) (left) in 11 joints (34.3%); of MCP 
(3) (right) in 14 joints (43.7%), and of MCP (3) (left) in 12 joints 
(37.5%). In addition, 102 (73.3%) and 37 (26.1%) cases of synovi-
tis were respectively detected in the dorsal and in the palmar 
recesses between MCP and PIP joints (Table 2).
On a semiquantitative scale, active synovitis was scored 2 
by PDUS, 9 (28.1%) in the left and 5 (15.6%) in the right wrist, 
featuring a moderate infl ammatory activity in the wrists. Syno-
vitis was graded 2 by GSUS, 6 (18.7%) and 4 (12.5%) in the dorsal 
recess of right and left MCP (2) joints, respectively. 
Subclinical synovitis was depicted in 6 (9.3%) wrists in 
DAS28 remission patients (DAS28 ≤2.6).
Comparison between clinical and US fi ndings 
For joints such as right wrists and certain small joints of the 
hands, the comparison of clinical and US fi ndings revealed 
Fig. 1 – Synovitis identifi ed by grayscale (GS) ultrasound and power Doppler (PD) ultrasound.
a = grade 0; b = grade 1; c = grade 2; d = grade 3. T: tendon; S: synovitis; R: radius; L: lunate; 
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that in 50% to 84% of the cases, swelling was associated with 
the presence of synovitis, as detected by US. In 50% of the 
cases, pain was found to be associated with the presence of 
synovitis in the PIP (5) (left) joint. No association was found 
for other examined joints (Table 3).
Clinical, laboratory, and imaging correlations
Positive, significant and moderate correlations were found for 
the presence of synovitis as detected by GSUS-examination of 
wrist with CRP results (r=0.42; p=0.0163), and for synovitis in 
the small joints of the toes, as detected by GSUS-examination, 
with HAQ-DI, RF, and CRP results (r=0.37 to 0.42; p=0.0161 to 
0.0337). PDUS-examination of wrist correlated with CRP re-
sults (r=0.40; p=0.00337) (Table 4).
A significant correlation was found between the presence 
of synovitis in the palmar recess of MCP (2) (right) and the 
period of treatment, or the dose of methotrexate (MTX) used 
(r=-0.36 to -0.37; p=0.0445 to p=0.0368). 
In the evaluation of the MUS7 score SYN, we found a sig-
nificant, moderate, and positive correlation between GSUS 
MUS7 score SYN and DAS28 (CRP) values (r=0.38; p=0,0332), 
and between PDUS MUS7 score SYN and CRP results (r=0.39; 
p=0.0280). 
There was an overall disagreement between rheumatolo-
gist’s evaluation of ultrasound and X-ray findings, as demon-
strated by the variation of kappa coefficient from -0.2000 95% 
CI (-0.4972, 0.0972) to 0.3333 95% CI (0.0469, 0.7136). 
Concerning the Larsen radiographic scoring, a good agree-
ment was observed between Reader 1 (rheumatologist) and 
Table 1 – Demographic data
Demographic data Mean ± SD Minimum Maximum Median
Disease duration (months) 13.2 ± 8.1 3 24 10
Age 42±14.6 20 75 45
DAS28 (CRP) 4.0±1.2 1.2 6.7 3.9
HAQ 1.2±0.7 0.0 2.9 1.3
ACPA (IU/dL) 137.2±95.8 0.0 250 161.9











DAS28, Disease Activity Score 28; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein;
HAQ, health assessment questionnaire score; ACPA, anti-cyclic citrullinated peptide; RF, rheumatoid factor.
Table 2 – Clinical and ultrasound data
N (%) Pain Swelling GSUS synovitis Dorsal  GSUS synovitis Palmar/
Plantar
 PDUS synovitis
Right WRIST 20 (62.50) 25 (78.3) 22 (68.75%) ND 12(37.51%)
Left WRIST 19 (59.38) 22 (68.75) 23(71.88%) ND 12(37.51%)
MCP, (2) (R) 17 (53.13) 23 (78.88) 18(56.25%) 7(21.88%)
MCP, (2) (L) 15 (46.88) 20 (62.59) 12(37.51%) 2(6.26%)
MCP, (3) (R) 16 (50.0) 20 (62.50) 15(46.88%) 6(18.76%)
MCP, (3) (L) 14 (43.75) 17 (53.13) 11(34.38%) 2(6.26%)
MCP, (4) (R) 13 (40.63) 11 (34.38) 9(28.13%) 0(0.00%)
MCP, (4) (L) 10 (31.25) 10 (31.25) 5(15.63%) 2(6.26%)
MCP, (5) (R) 7 (21.88) 6 (18.75) 5(15.63%) 1(3.13%)
MCP, (5) (L) 5 (15.63) 7 (21.88) 5(15.63%) 1(3.13%)
PIP, (2) (R) 8 (25.00) 7 (21.88) 4(12.50%) 1(3.13%)
PIP, (2) (L) 8 (25.00) 6 (18.75) 0 (0.00%) 2(6.26%)
PIP, (3) (R) 15 (46.88) 13 (40.63) 5(15.63%) 3(9.38%)
PIP, (3) (L) 9 (28.13) 6 (18.75) 5(15.63%) 6(18.76%)
PIP, (4) (R) 7 (21.88) 5 (15.63) 4(12.50%) 1(3.13%)
PIP, (4) (L) 7 (21.88) 7 (21.88) 1(3.13%) 1(3.13%)
PIP, (5) (R) 8 (25.00) 6 (18.75) 2(6.26%) 1(3.13%)
PIP, (5) (L) 6 (18.75) 4 (12.50) 1(3.13%) 1(3.13%)
MTP (2) (R) 2 (6.25) 1 (3.13) 3(9.39%) ND
MTP (2) (L) 0 (0.00) 0 (0.00) 2(6.26%) ND
MTP (3) (R) 2 (6.25) 1 (3.13) 3(9.39%) ND
MTP (3) (L) 1 (3.13) 0 (0.00) 3(9.39%) ND
MTP (4) (R) 1 (3.13) 0 (0.00) 1(3.13%) ND
MTP (4) (L) 1 (3.13) 0 (0.00) 2(6.26%) ND
MTP (5) (R) 1 (3.13) 0 (0.00) 1(3.13%) ND
MTP (5) (L) 1 (3.13) 0 (0.00) 2(6.26%) ND
MCP, Metacarpophalangeal joint; PIP, interproximal phalangeal; MTP, metatarsophalangeal joint; NA, not avaliable. 
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Reader 2 (radiologist) in the evaluation of some joints, such 
as the MCP (2) (right) and MCP (3) (left), as demonstrated by 
the variation of kappa coefficient from -0.062, 95% CI (-0.4020, 
0.2775) to 0.473 95% CI (0.1134, 0.8340). 
Discussion
In this study, we demonstrated the use of a modified US7 score 
in the assessment of synovitis in ERA. Moreover, as shown by 
our results, the dorsal recess, the wrist, and small joints can 
be considered as appropriate sites to detect synovitis by the 
MUS7 score SYN in patients with ERA. 
The inflammatory process in RA is generally identified by 
means of the clinical history, physical examination, and lab 
results, which can be characterized by an array of quality-of-
life instruments that may not always identify synovitis in its 
full activity. By the time it is detected by X-ray, the disease has 
already caused structural damage to the bone, with early le-
sions such as the presence of fluids and synovial cell prolifera-
tion.21-24 
The dissociation between clinical findings and US-detected 
synovial damage is even greater, including cases of remission 
in which clinical findings were not able to pinpoint the inflam-
matory inactivity. This study showed that 15.6% of patients in 
clinical remission presented synovitis with PD positive signal. 
Indeed, it has been shown that around 8% of patients in clini-
cal remission have subclinical synovitis by US examination.25,26 
Prospective longitudinal studies have clearly demonstrated 
that US, along with MRI, is more effective in identifying cases 
of remission, subclinical activity in asymptomatic patients, 
progression of structural damage, and improvement of syno-
vitis, highlighting its superior sensitivity and accuracy com-
pared to other methods, which enables an earlier intervention 
on the inflammatory activity of RA, and in the treatments ad-
opted.27,28 Studies have shown 75% to 79% agreement between 
US and MRI in the detection of synovitis, pointing to the diag-
nostic reliability of this method.29 A recent study showed that 
both techniques have good diagnostic performance for ERA.30 
In the global evaluation of the 832 joints, we found that the 
wrist was the most affected by moderately active synovitis, as 
detected by PD.31 GSUS-examination of the MCP and PIP joints 
of hands revealed a higher number of cases of synovitis in the 
dorsal recesses than in the palmar recesses. We found posi-
tive, significant and moderate correlations between the pres-
ence of synovitis of the right wrist, as detected by GSUS, of 
MTP (4) (left) joints, by PDUS and CRP results. This fact charac-
terizes CRP as an indicator of synovial inflammatory activity 
detected by US. 
This study showed that for most of the joints, joint swell-
ing as a clinical finding compares to the presence of synovitis 
as detected by US. We found negative correlation between the 
presence of synovitis in MCP (2) joints and the use of medica-
tion: the higher the dose and duration of methotrexate treat-
ment, the lower the detection of synovitis by US. This finding 
suggests that additional longitudinal studies should be carried 
out to confirm MTX as an effective DMARD in the initial dis-
ease. 
Regarding the evaluation of the 7 joints to elaborate the 
MUS7 score SYN, we found positive correlation between the 
simplified score results with DAS28 (CRP) and CRP results. 
Even though the MUS7 score SYN includes the analysis of only 
7 joints, as it excludes the evaluation of the palmar and ulnar 
recesses of the wrist joint, these results demonstrate that the 
dorsal recess is indicated for the detection of GS and PD sy-
novitis. 
The choice of some joints and dorsal recesses is considered 
promising for the diagnosis of synovitis in the early stage of 
ERA, when the disease is commonly misdiagnosed, resulting 
in uncertainty concerning treatment decisions, such as the 
type of treatment and the time to start it.32 US-examination 
of wrists and dorsal recess for the detection of synovitis was 
shown to be an important tool to confirm or to complement 
the ERA diagnosis, given that these were the joints that showed 
the worst synovial damage. Erosion was not much evident in 
our sample, possibly because we evaluated the disease at an 
Table 3 – Descriptive analysis and comparation between 




MCP, (2) (right)-SYN/swelling 69.57%
p= 0.0049
MCP, (3) (right)-SYN/swelling 60.00%
p= 0.0167
MCP, (5) (left)-SYN/swelling 50.00%
p= 0.0342
PIP, (3) (left)-SYN / swelling 66.67%
p= 0.0228
PIP, (5) (left)-SYN/swelling 75%
p= 0.0031
PIP, (5) (left)-SYN/pain 50%
p= 0.0149
SYN, Synovitis; MCP, Metacarpophalangeal joint; PIP, inter-proximal 
phalangeal 
Table 4 – Correlation of US data with clinical and 
laboratorial data on synovitis
 r/p-value
GSUS D of right wrist/CRP r= 0.42 
p= 0.0163
PDUS D of right wrist/CRP r = 0.40
p= 0.00337
GSUS D-MTP (2) (right)/RF r= 0.40
p= 0.0245
GSUS D-MTP (3) (right)/HAQ- DI r= 0.37
p= 0.0354
GSUS D-MTP (4) (right)/HAQ- DI r= 0.38
p= 0.0337
GSUS D-MTP, (4) (left)/CRP r= 0.42
p= 0.0161
PDUS D-of right wrist/ACPA r= -0.38
p= 0.0412
GSUS D-PIP (2) (right)/HAQ-DI r= -0.35
p= 0.0478
D, Dorsal longitudinal scan; GSUS, grayscale ultrasound; CRP, 
C-reactive Protein; MTP, metatarsophalangeal joint; RF, Rheumatoid 
factor; anti-cyclic citrullinated peptide (ACPA); HAQ-DI, health 
assessment questionnaire-disability.
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early stage.33-35 Wrist, MCP2 and MCP3 were the joints that 
were more affected by synovial inflammation in comparison 
to other joints. Our MUS7 score SYN results indicate the wrist 
and MCP2 as the most promising joints for ERA diagnosis and 
clinical follow-up. However, longitudinal studies are needed to 
validate this new score for synovitis identification in ERA.
Regarding clinical findings, we found that in 50% to 84% of 
the studied cases, joint swelling was associated with the pres-
ence of synovitis as detected by US. CRP can be considered a 
significant indicator of the presence of synovial inflammation, 
as confirmed by the images. The results obtained by means of 
the MUS7 score SYN in the evaluation of initial synovial in-
flammatory activity were associated with clinical and labora-
tory findings, once again indicating this modified score as an 
important tool for the initial diagnosis, and for the follow-up 
of patients with ERA. Active synovitis of the hands as detected 
by PDUS, analysed separately or along with 7 other joints by 
the MUS7 score SYN, can be an important predictor of the sy-
novial damage in ERA, as demonstrated by the correlation be-
tween PDUS and CRP results. The dorsal recess can be consid-
ered an important site to detect active synovitis by PD and GS. 
US is more precise than clinical examination in synovitis. 
US score shows some fundamental characteristics such as re-
producibility, viability, and sensitivity to change over time like 
was observed in the systematic review study.36
MUS7 score SYN was proven to be very useful if adopted in 
daily clinical practice, for the dianogsis and therapeutic man-
agement of patients with ERA, future studies may better vali-
date this score to evaluate synovitis.
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